PMOS Affects 1 in 5 Indian Women as Urban Lifestyles Raise Risk
Updated
Updated · The Indian Express · Jul 20
PMOS Affects 1 in 5 Indian Women as Urban Lifestyles Raise Risk
3 articles · Updated · The Indian Express · Jul 20
Summary
Recent studies suggest about 1 in 5 Indian women—and nearly 1 in 5 under 25—live with PMOS, well above the global prevalence of roughly 1 in 8.
Doctors say the rise reflects both better diagnosis and higher underlying risk from India’s metabolic profile, especially diabetes, insulin resistance and family history.
Urban habits are intensifying that risk: specialists link city prevalence of 25% to 40% to processed food, sedentary routines, poor sleep and rising stress.
Rural women still often go undiagnosed for years, with uneven awareness among families and smaller-town healthcare providers delaying treatment for a disorder that affects fertility, insulin regulation, cardiovascular health and mental wellbeing.
As PMOS surges in India, how can a girl in a village get the same life-saving diagnosis as someone in a city?
If PMOS is a 'societal biomarker,' is this epidemic a symptom of a much larger illness within modern Indian life?
From PCOS to PMOS: India’s High Prevalence, Unique Risks, and the Push for Holistic Women’s Health
Overview
Earlier this year, Polycystic Ovary Syndrome (PCOS) was officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) after a strong consensus among doctors, researchers, patients, and advocates. This change, driven by a collaborative effort of over 50 organizations, aims to move beyond the old focus on ovarian cysts and reproductive issues. The new name highlights the condition’s broader endocrine and metabolic nature, encouraging earlier screening for related health risks like diabetes and heart disease. By shifting the perspective from just reproductive health, the renaming seeks to improve understanding, reduce stigma, and promote better care for those affected.